XML 18 R4.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Net sales:      
Total net sales $ 21,595,199 $ 17,572,589 $ 13,850,372
Cost of sales:      
Total cost of sales 9,793,224 7,676,119 7,311,923
Gross profit 11,801,975 9,896,470 6,538,449
Operating expenses:      
Research and development 2,955,976 2,489,806 3,575,801
Selling, general and administrative 6,100,545 5,877,920 6,674,187
Total operating expenses 9,056,521 8,367,726 10,249,988
Operating income (loss) 2,745,454 1,528,744 (3,711,539)
Interest income 154,950 249,620 53,561
Other income 60,497 73,737 67,724
Income (loss) before income taxes 2,960,901 1,852,101 (3,590,254)
Income tax (benefit) expense (308,882) 1,805 63,651
Net income (loss) $ 3,269,783 $ 1,850,296 $ (3,653,905)
Net income (loss) per common share:      
Basic (in dollars per share) $ 0.19 $ 0.11 $ (0.22)
Diluted (in dollars per share) $ 0.19 $ 0.11 $ (0.22)
Weighted average shares outstanding:      
Basic (in shares) 16,939,302 16,867,550 16,805,991
Diluted (in shares) 17,114,191 16,942,447 16,805,991
Product      
Net sales:      
Total net sales $ 20,806,121 $ 16,165,333 $ 13,450,803
Cost of sales:      
Total cost of sales 9,568,553 7,038,717 7,120,731
Engineering development contracts      
Net sales:      
Total net sales 789,078 1,407,256 399,569
Cost of sales:      
Total cost of sales $ 224,671 $ 637,402 $ 191,192